Retrospective evaluation of LCP-tacrolimus (Envarsus XR) dosing in de novo kidney transplant.

Mohammed AlzahraniRachel M Belcher Jamie J BenkenBenito ValdepenasPierpaolo Di CoccoMathula KajavathananScott T Benken

Published in: Clinical transplantation (2023)

The use of LCPT in kidney transplant recipients with obesity dosed using TBW demonstrated the strongest correlation with initial supratherapeutic tacrolimus levels. Larger prospective studies are needed to investigate the further impact of body weight on dosing regimens in the obese population.

Keyphrases

body weight
weight loss
metabolic syndrome
type diabetes
insulin resistance
adipose tissue
bariatric surgery
cross sectional
high fat diet induced
case control
obese patients
physical activity